Evidence map›Paper›PMID 40061732›Full record

ArticleJournal of pharmacy & bioallied sciences2024

Effect of Passive Immunotherapeutics (IgY) on S. Mutans in Caries Active Children 8-11 Years of Age.

Antarmayee Panigrahi, Snigdha Pattanaik, Noorjahan Mohammad, Subhrajeet N Sahoo, Swati Patnaik, Debarchita Sarangi

Abstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Latest Findings in Immunoglobulin Y Technologies and Applications.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antarmayee PanigrahiDepartment of Pediatric and Preventive Dentistry, Institute of Dental Sciences, SOA Deemed to be University, Bhubaneswar, Odisha, India.
Snigdha PattanaikDepartment of Orthodontics, Pediatric and Community Dentistry, College of Dental Medicine, University of Sharjah, UAE.
Noorjahan MohammadDepartment of Pediatrics and Preventive Dentistry, Government Dental College, Silchar, Assam, India.
Subhrajeet N SahooDepartment of Orthodontics, Institute of Dental Sciences, Siksha 'O' Anusandhan University, Odisha, India.
Swati PatnaikDepartment of Public Health Dentistry, Institute of Dental Sciences, Siksha 'O' Anusandhan University, Odisha, India.
Debarchita SarangiDepartment of Prosthodontics, Institute of Dental Sciences, Siksha 'O' Anusandhan University, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Dental caries is a multifactorial disease caused by combined effect of host, environment, and microorganism. Mutans Streptococci (MS) is the main microorganism in causing and progression of dental caries. Advances in science and technology led to attempt in managing dental caries by targeting its initiation and delaying its progress. Immunoglobulin Y has proven efficacy in reducing the colonisation of S. Mutans by affecting the adhesion. Aim: Thus the present study was undertaken to evaluate the effect of passive immunisation on S.Mutans levels in caries active children aged 8-11 yrs of age. Materials and methods: Total of 50 children were randomly divided into IgY mouthspray (Test Group) and 0.9% Saline (Control group). Saliva sample were collected and subjected to microbial examination using MSB agar at the end of 30 days of study period. Results: Within the limitations, it can be concluded that IgY mouthspray significantly reduces the adhesion and growth of the causative agent S.Mutans in caries active children. Conclusion: Use of passive immunisation significantly reduces the bacterial overload and thus decreasing the dental caries in high risk children.

Indexed as

Early childhood cariesIgYimmunoglobulinpassive immunity

Identifiers

PMID40061732
PMCPMC11888708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.